One of the more impressive data sets at this year’s ESMO came from a Roche study of its drug divarasib, which treats lung cancer.
Back to Lifestyle
Lifestyle
October 26, 2026 at 11:17 PM
STAT+: Roche gets a lung cancer win with its KRAS drug divarasib
STAT News
Excerpt from STAT News.